Understanding Hepatic Sexual Dimorphism and Promoting Health Equity in Medicine
Hatched by George A
Aug 11, 2023
4 min read
4 views
Copy Link
Understanding Hepatic Sexual Dimorphism and Promoting Health Equity in Medicine
Introduction:
The study of hepatic sexual dimorphism and its implications for non-alcoholic fatty liver disease (NAFLD) has provided valuable insights into the progression of liver dysfunction and fibrosis. Numerous studies have identified signaling and metabolic pathways that contribute to liver dysfunction, with insulin resistance being a major initiating event driving de novo lipogenesis in the liver. Interestingly, there are physiological differences between sexes that impact whole-body insulin sensitivity, highlighting the importance of considering sex as a biological variable in research. Moreover, the presence of sexual dimorphism extends beyond the liver, affecting various organs and cell types. In this article, we will explore the implications of hepatic sexual dimorphism for NAFLD and discuss the importance of promoting health equity in medicine.
Sexual Dimorphism and Insulin Sensitivity:
One of the key differences between men and women is their insulin sensitivity. Women tend to exhibit higher insulin sensitivity, which promotes liver homeostasis. This can be attributed to several factors, including the location and function of white adipose tissue (WAT) depots. In women, WAT depots are primarily subcutaneous, highly expandable, and produce larger amounts of the insulin-sensitizing hormone adiponectin. Additionally, pre-menopausal women have increased insulin sensitivity in skeletal muscles, enhancing their capacity to extract triglycerides. These metabolic advantages enable women to adapt more effectively to lipid overload.
By contrast, men have primarily visceral WAT depots, which produce pro-inflammatory cytokines and are associated with cardiometabolic diseases. The differences in white adipose tissue distribution and function contribute to the higher incidence of advanced grades of NAFLD and fibrosis in men compared to women. Furthermore, men are more susceptible to developing hepatocellular carcinoma (HCC) related to NAFLD. This sex bias is observed in both human and mouse studies, suggesting that it goes beyond differences in risk factor exposure. It is important to note that while women may be protected from HCC development, they may experience more aggressive progression of other liver pathologies.
The Need for Considering Sex as a Biological Variable:
Despite the clear existence of sexual dimorphism in various aspects of liver function and disease, sex is often overlooked as a biological variable in research studies. This oversight undermines our understanding of the intrinsic molecular mechanisms underlying the development of NAFLD and its comorbidities in males. To gain a comprehensive understanding of the disease, it is crucial to consider the influence of sex on liver function and pathology.
Promoting Health Equity in Medicine:
In the field of medicine, it is essential to address health disparities and promote health equity. The work of healthcare leaders like Dr. Olaoluwa Fayanju, Regional Medical Director of Oak Street Health in Chicago, exemplifies the commitment to serving vulnerable and underserved patients. Dr. Fayanju has played a pivotal role in Oak Street Health's diversity, equity, and inclusion committee, actively working to combat racism in medicine. His efforts extend beyond patient care, as he led an initiative to register patients and colleagues to vote ahead of the 2020 election. Dr. Fayanju's contributions were recognized by the White House, which invited him to participate in its Health Equity Leaders Roundtable Series.
Actionable Advice:
- 1. Incorporate sex as a biological variable in research studies: Researchers should include both male and female subjects in their studies to account for sexual dimorphism in liver function and disease. This will lead to a more comprehensive understanding of the underlying mechanisms and potential sex-specific treatments for NAFLD.
- 2. Promote diversity, equity, and inclusion in healthcare: Healthcare organizations should prioritize diversity, equity, and inclusion initiatives to address health disparities and promote equitable access to care. This includes fostering a diverse workforce and creating an inclusive environment that values the experiences and perspectives of all patients.
- 3. Advocate for policy changes to address health inequities: Healthcare leaders, like Dr. Fayanju, can use their platform to advocate for policy changes that address systemic issues contributing to health disparities. This can involve supporting initiatives aimed at reducing racial and socioeconomic barriers to healthcare access and promoting health equity on a broader scale.
Conclusion:
Understanding hepatic sexual dimorphism is crucial for unraveling the complexities of NAFLD and developing targeted therapies. The physiological differences between men and women contribute to variations in liver function, disease progression, and treatment response. By considering sex as a biological variable in research studies, we can gain valuable insights into the molecular mechanisms underlying NAFLD and its comorbidities. Furthermore, promoting health equity in medicine is essential to ensure that all individuals, regardless of their sex or other demographic factors, have equal access to quality healthcare. By incorporating actionable advice such as incorporating sex as a biological variable, promoting diversity and inclusion, and advocating for policy changes, we can work towards a more equitable healthcare system that addresses the needs of all patients.
Resource:
Copy Link